Immunohistochemical staining of tumors showed that 25HC had no inhibitory effect on proliferation of lung cancer (PCNA, whereas 25HC plus gilteritinib reduced the number of PCNA-positive cells (Fig. 7D). Here, PCNA is linked to lung cancer.